Bioactive lipids, inflammation and chronic diseases

A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …

Ceramides in autoimmune rheumatic diseases: existing evidence and therapeutic considerations for diet as an anticeramide treatment

I Alexandropoulou, MG Grammatikopoulou… - Nutrients, 2023 - mdpi.com
Autoimmune rheumatic diseases (AIRDs) constitute a set of connective tissue disorders and
dysfunctions with akin clinical manifestations and autoantibody responses. AIRD treatment …

Sphingosine 1-phosphate signaling during infection and immunity

S Mohammed, A Bindu, A Viswanathan… - Progress in Lipid …, 2023 - Elsevier
Sphingolipids are essential components of all eukaryotic membranes. The bioactive
sphingolipid molecule, Sphingosine 1-Phosphate (S1P), regulates various important …

S1P increases VEGF production in osteoblasts and facilitates endothelial progenitor cell angiogenesis by inhibiting miR-16-5p expression via the c-Src/FAK signaling …

CC Huang, TT Tseng, SC Liu, YY Lin, YY Law, SL Hu… - Cells, 2021 - mdpi.com
Angiogenesis is a critical process in the formation of new capillaries and a key participant in
rheumatoid arthritis (RA) pathogenesis. Vascular endothelial growth factor (VEGF) …

the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis‐a unique therapeutic target in inflammatory bowel disease

J Wang, I Goren, B Yang, S Lin, J Li… - Alimentary …, 2022 - Wiley Online Library
Background Ozanimod, a high selective sphingosine 1 phosphate (S1P) receptor (S1PR)
1/5 modulator was approved by the Food and Drug Administration for the treatment of adult …

Functional lipids in autoimmune inflammatory diseases

MD Cas, G Roda, F Li, F Secundo - International journal of molecular …, 2020 - mdpi.com
Lipids are apolar small molecules known not only as components of cell membranes but
also, in recent literature, as modulators of different biological functions. Herein, we focused …

Lipids in liver failure syndromes: a focus on eicosanoids, specialized pro-resolving lipid mediators and lysophospholipids

F Artru, MJW McPhail, E Triantafyllou… - Frontiers in …, 2022 - frontiersin.org
Lipids are organic compounds insoluble in water with a variety of metabolic and non-
metabolic functions. They not only represent an efficient energy substrate but can also act as …

Comparison of immune cells and diagnostic markers between spondyloarthritis and rheumatoid arthritis by bioinformatics analysis

J Wang, Y Xue, L Zhou - Journal of Translational Medicine, 2022 - Springer
Abstract Background Spondyloarthritis (SpA) and rheumatoid arthritis (RA) are chronic
autoimmune diseases, but they are usually difficult to distinguish in the early stage of the …

[HTML][HTML] S1P/S1PR signaling pathway advancements in autoimmune diseases

J Li, Y Huang, Y Zhang, P Liu, M Liu… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
Abstract Sphingosine-1-phosphate (S1P) is a versatile sphingolipid that is generated
through the phosphorylation of sphingosine by sphingosine kinase (SPHK). S1P exerts its …

[HTML][HTML] Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate

D Liu, J Liu, Y Li, L Du, Q Cao, L Yang, Y Zhou, P Chen… - iScience, 2024 - cell.com
Benign prostatic hyperplasia (BPH) is a common condition in aging males, but its underlying
pathogenesis remains unclear. Sphingosine-1-phosphate (S1P) and its receptors (S1PRs) …